Medication info
Rosuvastatin Calcium Tablet 20mg

Rosuvastatin Calcium Tablet 20mg

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
Pink circular film-coated tablet
Packaging
28 tablets/Alu-Alu[(14 tablets/Alu-Alu x 2)]
Approval status
Active

MFDS item code 201601553 · Approved 2016.03.17 · Insurance code 660702950

Summary

Main use
Treatment of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; the dose may be adjusted to a maintenance dose if greater LDL-cholesterol reduction is required. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL-cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. This medicine should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. The 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. The 40 mg dose of this medicine is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Doses should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular disease

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • homozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • coronary artery disease
  • stroke
  • myocardial infarction
View approved original text

This drug is primarily used for patients with hypercholesterolemia and hyperlipidemia. It helps lower blood cholesterol levels in patients with primary hypercholesterolemia and mixed hyperlipidemia that are not controlled by diet and exercise. It is also used for pediatric patients with heterozygous familial hypercholesterolemia and homozygous familial hypercholesterolemia, reducing total and LDL cholesterol. Additionally, it is used as an adjunct to diet in patients with primary dysbetalipoproteinemia. In adults at high risk for cardiovascular disease, it aids in the reduction of the risk of complications related to stroke, myocardial infarction, and vascular revascularization. Overall, this medication is used to improve blood lipid levels and reduce the progression and risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; the dose may be adjusted to a maintenance dose if greater LDL-cholesterol reduction is required. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL-cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. This medicine should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. The 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. The 40 mg dose of this medicine is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Doses should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. Patients who are allergic to this medication, have severely impaired liver function, have muscle disorders, are taking certain immunosuppressants, have severe kidney function impairment, or are pregnant or breastfeeding should not take this medication. Women of childbearing potential may only take this medication if they are very likely not to be pregnant and fully understand the risks to the fetus. For the 40mg dose, it should not be administered to patients at high risk for muscle disorders, and patients with lactose intolerance should also avoid it. Furthermore, patients with a history of liver disease or those who consume excessive alcohol should frequently monitor their liver function while taking this medication. If someone has hypothyroidism or nephrotic syndrome, this medication should only be used after treating the underlying cause. If muscle pain or weakness occurs while taking this drug, the patient must immediately inform their doctor and undergo examination. If muscle-related symptoms are severe or laboratory findings are abnormal, the medication may need to be discontinued. Patients with acute severe illness or muscle weakness symptoms should also use this drug with caution. The risk of muscle-related side effects may increase when combined with other medications, so caution is necessary during concomitant use. This medication can affect liver function, so it should be discontinued promptly if symptoms of liver damage occur. Blood glucose levels may rise, so patients at risk for diabetes should regularly check their blood sugar levels. The concentration of the drug in the body may vary depending on certain genetic traits, necessitating dosage adjustments for individual patients. If serious skin reactions occur, the medication should be stopped immediately and medical consultation should occur. There may be interactions with other medications, so if any other medications are being taken, it is essential to inform healthcare providers. Special caution is required when combined with certain antiviral agents, immunosuppressants, and fibrates. Pregnant or breastfeeding women should not use this medication, and women planning to become pregnant should use appropriate birth control methods. In cases of overdose, there is no specific antidote, and treatment should be symptomatic, including monitoring liver function and muscle enzyme levels. Care should be taken while driving or operating machinery, as dizziness may occur. Long-term use of this drug may lead to rare side effects like interstitial lung disease, so if symptoms such as shortness of breath or cough appear, immediate consultation with a healthcare provider is necessary.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug eruption resembling psoriasis, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, widespread pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Pink circular film-coated tablet

Package unit

28 tablets/Alu-Alu[(14 tablets/Alu-Alu x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.